ABSTRACT
BACKGROUND: Bipolar disorder (BD) is a psychiatric disorder with an uncertain aetiology. Recently, special attention has been given to homocysteine (Hcy), as it has been suggested that alterations in 1-carbon metabolism might be implicated in diverse psychiatric disorders. However, there is uncertainty regarding possible alterations in peripheral Hcy levels in BD. METHODS: This study comprises a meta-analysis comparing serum and plasma Hcy levels in persons with BD and healthy controls. We conducted a systematic search for all eligible English and non-English peer-reviewed articles. RESULTS: Nine cross-sectional studies were included in the meta-analyses, providing data on 1547 participants. Random-effects meta-analysis showed that serum and plasma levels of Hcy were increased in subjects with BD in either mania or euthymia when compared to healthy controls, with a large effect size in the mania group (g=0.98, 95% CI: 0.8-1.17, P<0.001, n=495) and a small effect in the euthymia group (g=0.3, 95% CI: 0.11-0.48, P=0.002, n=1052). CONCLUSIONS: Our meta-analysis provides evidence that Hcy levels are elevated in persons with BD during mania and euthymia. Peripheral Hcy could be considered as a potential biomarker in BD, both of trait (since it is increased in euthymia), and also of state (since its increase is more accentuated in mania). Longitudinal studies are needed to clarify the relationship between bipolar disorder and Hcy, as well as the usefulness of peripheral Hcy as both a trait and state biomarker in BD.
Subject(s)
Bipolar Disorder/diagnosis , Cyclothymic Disorder/diagnosis , Homocysteine/blood , Biomarkers/blood , Bipolar Disorder/blood , Cross-Sectional Studies , Cyclothymic Disorder/blood , HumansABSTRACT
AIMS/HYPOTHESIS: Urocortins are the endogenous ligands for the corticotropin-releasing factor receptor type 2 (CRFR2), which is implicated in regulating energy balance and/or glucose metabolism. We determined the effects of chronic CRFR2 activation on metabolism in vivo, by generating and phenotyping transgenic mice overproducing the specific CRFR2 ligand urocortin 3. METHODS: Body composition, glucose metabolism, insulin sensitivity, energy efficiency and expression of key metabolic genes were assessed in adult male urocortin 3 transgenic mice (Ucn3(+)) under control conditions and following an obesogenic high-fat diet (HFD) challenge. RESULTS: Ucn3(+) mice had increased skeletal muscle mass with myocyte hypertrophy. Accelerated peripheral glucose disposal, increased respiratory exchange ratio and hypoglycaemia on fasting demonstrated increased carbohydrate metabolism. Insulin tolerance and indices of insulin-stimulated signalling were unchanged, indicating these effects were not mediated by increased insulin sensitivity. Expression of the transgene in Crfr2 (also known as Crhr2)-null mice negated key aspects of the Ucn3(+) phenotype. Ucn3(+) mice were protected from the HFD-induced hyperglycaemia and increased adiposity seen in control mice despite consuming more energy. Expression of uncoupling proteins 2 and 3 was higher in Ucn3(+) muscle, suggesting increased catabolic processes. IGF-1 abundance was upregulated in Ucn3(+) muscle, providing a potential paracrine mechanism in which urocortin 3 acts upon CRFR2 to link the altered metabolism and muscular hypertrophy observed. CONCLUSIONS/INTERPRETATION: Urocortin 3 acting on CRFR2 in skeletal muscle of Ucn3(+) mice results in a novel metabolically favourable phenotype, with lean body composition and protection against diet-induced obesity and hyperglycaemia. Urocortins and CRFR2 may be of interest as potential therapeutic targets for obesity.
Subject(s)
Dietary Fats/adverse effects , Hyperglycemia/metabolism , Hyperglycemia/prevention & control , Obesity/metabolism , Obesity/prevention & control , Urocortins/genetics , Urocortins/metabolism , Animals , Body Composition/drug effects , Body Composition/physiology , Dietary Fats/pharmacology , Disease Models, Animal , Energy Metabolism/drug effects , Energy Metabolism/physiology , Glucose/metabolism , Insulin/blood , Insulin-Like Growth Factor I/metabolism , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Phenotype , Receptors, Corticotropin-Releasing Hormone/deficiency , Receptors, Corticotropin-Releasing Hormone/genetics , Receptors, Corticotropin-Releasing Hormone/metabolismABSTRACT
BACKGROUND: The traditional approach to resolving ethics concerns may not address underlying organisational issues involved in the evolution of these concerns. This represents a missed opportunity to improve quality of care "upstream". The purpose of this study was to understand better which organisational issues may contribute to ethics concerns. METHODS: Directed content analysis was used to review ethics consultation notes from an academic children's hospital from 1996 to 2006 (N = 71). The analysis utilised 18 categories of organisational issues derived and modified from published quality improvement protocols. RESULTS: Organisational issues were identified in 68 of the 71 (96%) ethics consult notes across a range of patient settings and reasons for consultation. Thirteen of the 18 categories of organisational issues were identified and there was a median of two organisational issues per consult note. The most frequently identified organisational issues were informal organisational culture (eg, collective practices and approaches to situations with ethical dimensions that are not guided by policy), policies and procedures (eg, staff knows policy and/or procedural guidelines for an ethical concern but do not follow it) and communication (eg, communication about critical information, orders, or hand-offs repeatedly does not occur among services). CONCLUSIONS: Organisational issues contribute to ethical concerns that result in clinical ethics consults. Identifying and addressing organisational issues such as informal culture and communication may help decrease the recurrence of future similar ethics concerns.
Subject(s)
Ethics Consultation/ethics , Ethics, Clinical , Organizational Policy , Pediatrics/ethics , Adolescent , Child , Child, Preschool , Ethics Consultation/organization & administration , Ethics Consultation/standards , Humans , Infant , Infant, Newborn , Organizational Culture , Organizational Objectives , Pediatrics/organization & administration , Pediatrics/standards , Qualitative Research , WashingtonABSTRACT
Glucocorticoid hormones are critical to respond and adapt to stress. Genetic variations in the glucocorticoid receptor (GR) gene alter hypothalamic-pituitary-adrenal (HPA) axis activity and associate with hypertension and susceptibility to metabolic disease. Here we test the hypothesis that reduced GR density alters blood pressure and glucose and lipid homeostasis and limits adaption to obesogenic diet. Heterozygous GR(betageo/+) mice were generated from embryonic stem (ES) cells with a gene trap integration of a beta-galactosidase-neomycin phosphotransferase (betageo) cassette into the GR gene creating a transcriptionally inactive GR fusion protein. Although GR(betageo/+) mice have 50% less functional GR, they have normal lipid and glucose homeostasis due to compensatory HPA axis activation but are hypertensive due to activation of the renin-angiotensin-aldosterone system (RAAS). When challenged with a high-fat diet, weight gain, adiposity, and glucose intolerance were similarly increased in control and GR(betageo/+) mice, suggesting preserved control of intermediary metabolism and energy balance. However, whereas a high-fat diet caused HPA activation and increased blood pressure in control mice, these adaptions were attenuated or abolished in GR(betageo/+) mice. Thus, reduced GR density balanced by HPA activation leaves glucocorticoid functions unaffected but mineralocorticoid functions increased, causing hypertension. Importantly, reduced GR limits HPA and blood pressure adaptions to obesogenic diet.
Subject(s)
Blood Pressure/drug effects , Diet/adverse effects , Dietary Fats/adverse effects , Hypertension/metabolism , Hypothalamo-Hypophyseal System/metabolism , Pituitary-Adrenal System/metabolism , Receptors, Glucocorticoid/metabolism , Adiposity/drug effects , Adiposity/genetics , Aldosterone/metabolism , Angiotensins/metabolism , Animals , Blood Glucose/metabolism , Cell Line , Dietary Fats/pharmacology , Glucose Intolerance/genetics , Glucose Intolerance/metabolism , Humans , Hypertension/chemically induced , Hypertension/genetics , Lipid Metabolism/genetics , Mice , Mice, Transgenic , Receptors, Glucocorticoid/genetics , Renin/metabolism , Weight Gain/drug effects , Weight Gain/geneticsABSTRACT
Translation elongation factor eEF1A, formerly known as EF-1 alpha, exists as two variant forms; eEF1A1, which is almost ubiquitously expressed, and eEF1A2, whose expression is restricted to muscle and brain at the level of whole tissues. Expression analysis of these genes has been complicated by a general lack of availability of antibodies that specifically recognize each variant form. Wasted mice (wst/wst) have a 15.8-kilobase deletion that abolishes activity of eEF1A2, but before this study it was unknown whether the deletion also affected neighboring genes. We have generated a panel of anti-peptide antibodies and used them to show that eEF1A2 is expressed at high levels in specific cell types in tissues previously thought not to express this variant, such as pancreatic islet cells and enteroendocrine cells in colon crypts. Expression of eEF1A1 and eEF1A2 is shown to be generally mutually exclusive, and we relate the expression pattern of eEF1A2 to the phenotype seen in wasted mice. We then carried out a series of transgenic experiments to establish whether the expression of other genes is affected by the deletion in wasted mice. We show that aspects of the phenotype such as motor neuron degeneration relate precisely to the relative expression of eEF1A1 and eEF1A2, whereas the immune system abnormalities are likely to result from a stress response. We conclude that loss of eEF1A2 function is solely responsible for the abnormalities seen in these mice.
Subject(s)
Gene Expression Regulation , Immune System/metabolism , Peptide Elongation Factor 1/biosynthesis , Wasting Syndrome/metabolism , Animals , Base Sequence/genetics , Colon/immunology , Colon/metabolism , Colon/pathology , Gene Expression Regulation/immunology , Humans , Immune System/abnormalities , Insulin-Secreting Cells/immunology , Insulin-Secreting Cells/metabolism , Insulin-Secreting Cells/pathology , Mice , Mice, Mutant Strains , Mice, Transgenic , Motor Neuron Disease/genetics , Motor Neuron Disease/immunology , Motor Neuron Disease/metabolism , Motor Neuron Disease/pathology , Organ Specificity/genetics , Organ Specificity/immunology , Peptide Elongation Factor 1/genetics , Peptide Elongation Factor 1/immunology , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , Protein Isoforms/immunology , Sequence Deletion , Wasting Syndrome/genetics , Wasting Syndrome/immunology , Wasting Syndrome/pathology , WeaningABSTRACT
Ercc1 has an essential role in the nucleotide excision repair (NER) pathway that protects against ultraviolet (UV)-induced DNA damage and is also involved in additional repair pathways. The premature death of simple Ercc1 mouse knockouts meant that we were unable to study the role of Ercc1 in the skin. To do this, we have used the Cre-lox system to generate a skin-specific Ercc1 knockout. With a Cre transgene under control of the bovine keratin 5 promoter we achieved 100% recombination of the Ercc1 gene in the epidermis. Hairless mice with Ercc1-deficient skin were hypersensitive to the short-term effects of UV irradiation, showing a very low minimal erythemal dose and a dramatic hyperproliferative response. Ultraviolet-irradiated mice with Ercc1-deficient skin developed epidermal skin tumours much more rapidly than controls. These tumours appeared to arise earlier in actinic progression and grew more rapidly than tumours on control mice. These responses are more pronounced than have been reported for other NER-deficient mice, demonstrating that Ercc1 has a key role in protecting against UV-induced skin cancer.
Subject(s)
DNA Repair/genetics , DNA-Binding Proteins/physiology , Endonucleases/physiology , Epidermis/enzymology , Neoplasms, Radiation-Induced/enzymology , Skin Neoplasms/enzymology , Ultraviolet Rays/adverse effects , Animals , DNA/radiation effects , DNA Damage , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Disease Progression , Endonucleases/deficiency , Endonucleases/genetics , Epidermis/pathology , Epidermis/radiation effects , Female , Gene Targeting , Genes, Lethal , Integrases , Male , Mice , Mice, Hairless , Mice, Knockout , Neoplasms, Radiation-Induced/genetics , Organ Specificity , Skin Neoplasms/genetics , TransgenesABSTRACT
A four-year-old, entire male toy poodle was presented with a two-and-a-half-week history of ocular discharge progressing to periorbital alopecia, depigmentation, alopecia and ulceration around the muzzle. There was also a haemorrhagic discharge from the ears, pyrexia, lethargy and generalised lymphadenopathy. The clinical, cytological, bacteriological and histopathological findings were consistent with a diagnosis of dermatitis resembling juvenile cellulitis in an adult dog. Glucocorticoid therapy led to rapid resolution of the clinical signs and the dog has remained in remission for two years after cessation of treatment.
Subject(s)
Cellulitis/veterinary , Dermatitis, Perioral/veterinary , Dog Diseases/diagnosis , Alopecia/etiology , Alopecia/veterinary , Animals , Blood Chemical Analysis/veterinary , Cellulitis/complications , Cellulitis/diagnosis , Dermatitis, Perioral/complications , Dermatitis, Perioral/diagnosis , Diagnosis, Differential , Dog Diseases/drug therapy , Dog Diseases/pathology , Dogs , Glucocorticoids/therapeutic use , MaleABSTRACT
Toxoplasma gondii-associated meningoencephalitis is a significant disease of California sea otters (Enhydra lutris nereis), responsible for 16% of total mortality in fresh, beachcast carcasses. Toxoplasma gondii isolates were obtained from 35 California otters necropsied between 1998 and 2002. Based on multi-locus PCR-restriction fragment length polymorphism and DNA sequencing at conserved genes (18S rDNA, ITS-1) and polymorphic genes (B1, SAG1, SAG3 and GRA6), two distinct genotypes were identified: type II and a novel genotype, here called type x, that possessed distinct alleles at three of the four polymorphic loci sequenced. The majority (60%) of sea otter T. gondii infections were of genotype x, with the remaining 40% being of genotype II. No type I or III genotypes were identified. Epidemiological methods were used to examine the relationship between isolated T. gondii genotype(s) and spatial and demographic risk factors, such as otter stranding location and sex, as well as specific outcomes related to pathogenicity, such as severity of brain inflammation on histopathology and T. gondii-associated mortality. Differences were identified with respect to T. gondii genotype and sea otter sex and stranding location along the California coast. Localised spatial clustering was detected for both type II (centred within Monterey Bay) and x (centred near Morro Bay)-infected otters. The Morro Bay cluster of type x-infected otters overlaps previously reported high-risk areas for sea otter infection and mortality due to T. gondii. Nine of the 12 otters that had T. gondii-associated meningoencephalitis as a primary cause of death were infected with type x parasites.
Subject(s)
Otters/parasitology , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/parasitology , Animals , Base Sequence , California/epidemiology , DNA, Protozoan/genetics , Disease Susceptibility , Genotype , Molecular Sequence Data , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Risk Factors , Sex Factors , Toxoplasma/genetics , Toxoplasma/isolation & purification , Toxoplasmosis, Animal/mortality , Toxoplasmosis, Animal/pathologyABSTRACT
Tachykinins function not only as neurotransmitters but also as immunological mediators. We used infection of tachykinin-deficient (PPT-A(-/-)) mice and wild-type controls with murine gammaherpesvirus to assess the role of tachykinins in the host response to a virus infection. Although infection was ultimately controlled in PPT-A(-/-) mice, there were higher titers of infectious virus in the lungs, accompanied by a more rapid influx of inflammatory cells. Clearance of latently infected cells from the spleen was also delayed. This is the first report of the direct influence of tachykinins in the host response to a virus infection.
Subject(s)
Gammaherpesvirinae , Herpesviridae Infections/immunology , Protein Precursors/physiology , Tachykinins/physiology , Animals , Lung/pathology , Lung/virology , Mice , Mice, Transgenic , Protein Precursors/genetics , Splenomegaly/etiology , Tachykinins/geneticsABSTRACT
Soft tissue foreign bodies (FB) represent a common cause for emergency department visits. Diagnosis may be difficult especially with non-radiopaque FB. The clinical course may be complicated by superficial or deep tissue infection. Use of imaging modalities such as ultrasound may be important for early diagnosis. We report a case of retained foreign body with a complicated clinical course and discuss imaging modalities that may have aided in the early diagnosis.
Subject(s)
Fasciitis, Necrotizing/etiology , Foreign Bodies/complications , Thigh , Wood , Child , Emergency Service, Hospital , Foreign Bodies/diagnosis , Foreign Bodies/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Sensitivity and Specificity , Tomography, X-Ray Computed , UltrasonographyABSTRACT
Murine gammaherpesvirus-68 (MHV-68) infection in interferon-gamma receptor knockout mice (IFN-gammaR(-)/(-)) results in splenic fibrosis and excessive loss of splenocytes. In our present study we found that MHV-68 infection in IFN-gammaR(-)/(-) mice also resulted in fibrosis and atrophy of the mediastinal lymph nodes, interstitial pulmonary fibrosis and fibrotic changes in the liver. Atrophy and cellular depletion of the spleen in IFN-gammaR(-)/(-) was not the result of increased cell death. The loss of splenocytes in IFN-gammaR(-)/(-) mice, which was most evident on day 23 after infection, correlated with an increase in the number of leukocytes in peripheral blood. At the peak of leukocytosis, on day 23 after infection, peripheral blood cells from infected IFN-gammaR(-)/(-) mice were unable to traffic through the fibrosed spleens of IFN-gammaR(-)/(-) mice but were able to enter the spleens of wild-type mice. This indicates that leukocytosis was in part the result of emigration of cells from the spleen and their subsequent exclusion of re-entry at the height of fibrosis. Significant cytokine and chemokine changes were observed in spleens of IFN-gammaR(-)/(-) mice. IFN-gamma, tumor necrosis factor-alpha (TNF-alpha ), TNF-beta, interleukin-1beta (IL-1beta), transforming growth factor-beta1 (TGF-beta1), lymphotactin, and MIP-1beta were elevated on day 14 after infection whereas chemokines IP-10 and MIG were significantly reduced. These changes suggest a role for dysregulated cytokines and chemokines in severe organ-specific fibrosis with implications for immune-mediated fibrotic disorders.
Subject(s)
Gammaherpesvirinae , Herpesviridae Infections/pathology , Leukocytosis/virology , Receptors, Interferon/genetics , Animals , Apoptosis , Chemokines/biosynthesis , Chemokines/genetics , Cytokines/biosynthesis , Cytokines/genetics , Fibrosis , Herpesviridae Infections/metabolism , Kinetics , Leukocyte Count , Liver Cirrhosis/pathology , Liver Cirrhosis/virology , Lymph Nodes/pathology , Mice , Mice, Knockout , Neutrophils , Pulmonary Fibrosis/pathology , Pulmonary Fibrosis/virology , RNA, Messenger/biosynthesis , Spleen/metabolism , Spleen/pathology , Interferon gamma ReceptorABSTRACT
Infection of mice by murine gammaherpesvirus 68 (MHV-68) is an excellent small-animal model of gammaherpesvirus pathogenesis in a natural host. We have carried out comparative studies of another herpesvirus, murine herpesvirus 76 (MHV-76), which was isolated at the same time as MHV-68 but from a different murid host, the yellow-necked mouse (Apodemus flavicollis). Molecular analyses revealed that the MHV-76 genome is essentially identical to that of MHV-68, except for deletion of 9,538 bp at the left end of the unique region. MHV-76 is therefore a deletion mutant that lacks four genes unique to MHV-68 (M1, M2, M3, and M4) as well as the eight viral tRNA-like genes. Replication of MHV-76 in cell culture was identical to that of MHV-68. However, following infection of mice, MHV-76 was cleared more rapidly from the lungs. In line with this, there was an increased inflammatory response in lungs with MHV-76. Splenomegaly was also significantly reduced following MHV-76 infection, and much less latent MHV-76 was detected in the spleen. Nevertheless, MHV-76 maintained long-term latency in the lungs and spleen. We utilized a cosmid containing the left end of the MHV-68 genome to reinsert the deleted sequence into MHV-76 by recombination in infected cells, and we isolated a rescuant virus designated MHV-76(cA8+)4 which was ostensibly genetically identical to MHV-68. The growth properties of the rescuant in infected mice were identical to those of MHV-68. These results demonstrate that genetic elements at the left end of the unique region of the MHV-68 genome play vital roles in host evasion and are critical to the development of splenic pathology.
Subject(s)
Gammaherpesvirinae/genetics , Genes, Viral , Herpesviridae Infections/virology , Animals , Blotting, Southern , Cell Line , DNA, Viral/analysis , Gammaherpesvirinae/pathogenicity , Gene Deletion , Herpesviridae Infections/pathology , Lung/pathology , Lung/virology , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Muridae , Vasculitis/pathology , Virus Latency , Viscera/virologySubject(s)
Cattle Diseases/pathology , Diabetes Mellitus/veterinary , Islets of Langerhans/pathology , Lymphocytosis/veterinary , Animals , Cattle , Cattle Diseases/virology , Diabetes Complications , Diarrhea Viruses, Bovine Viral/immunology , Enzyme-Linked Immunosorbent Assay/veterinary , Fever/etiology , Fever/veterinary , Lymphocytosis/pathology , MaleABSTRACT
BACKGROUND AND PURPOSE: The clinical presentation, diagnosis, histopathologic findings, and elimination of dual respiratory tract infection with Pasteurella pneumotropica and Pneumocystis carinii were studied in 100 adult barrier-reared C.B17 and MRL- lpr mice homozygous for a targeted mutation of the JH region of the immunoglobulin heavy chain. METHODS: Necropsy, aerobic bacteriologic culture of hematogenous and pulmonary tissues, histochemical staining of pulmonary tissues, polymerase chain reaction analysis of pulmonary tissues and feces, and viral serologic testing were performed on 19 clinically affected mice and 8 clinically normal mice, then later on antibiotic-treated and caesarian re-derived mice. Therapeutic strategies included sequential administration of trimethoprim/ sulfamethoxazole and enrofloxacin or enrofloxacin administration and caesarian rederivation. RESULTS: Clinically affected mice had diffuse, nonsuppurative, interstitial pneumonia with superimposed pyogranulomatous lobar pneumonia that was detected microscopically. Affected lung tissue yielded pure culture of P. pneumotropica. Aged-matched, clinically normal mice of both genotypes had interstitial histiocytic pneumonia without lobar pneumonia, and P. pneumotropica was not isolated. Histochemical staining of lung tissues from normal and clinically affected mice revealed scattered cysts consistent with P. carinii, principally in the interstitium. Treatment with sulfamethoxazole/trimethoprim and enrofloxacin eliminated bacteriologic detection of P. pneumotropica, decreased mortality from 50% to 6%, and improved breeding performance. CONCLUSION: A successful antibiotic therapy and rederivation approach, incorporating enrofloxacin, cesarian section, and isolator rearing, was developed for B cell-deficient mice with opportunistic infections.
Subject(s)
Fluoroquinolones , Mice, Inbred ICR/immunology , Pasteurella Infections/veterinary , Pneumonia, Bacterial/veterinary , Pneumonia, Pneumocystis/veterinary , Rodent Diseases/diagnosis , Animals , Anti-Bacterial Agents , Anti-Infective Agents/therapeutic use , Antineoplastic Agents/therapeutic use , B-Lymphocytes/immunology , Cesarean Section/veterinary , DNA, Bacterial/chemistry , DNA, Bacterial/isolation & purification , Enrofloxacin , Feces/microbiology , Female , Immunohistochemistry , Lung/microbiology , Lung/pathology , Male , Mice , Pasteurella/drug effects , Pasteurella/genetics , Pasteurella/immunology , Pasteurella Infections/complications , Pasteurella Infections/diagnosis , Pasteurella Infections/drug therapy , Pneumocystis/drug effects , Pneumocystis/genetics , Pneumocystis/immunology , Pneumonia, Bacterial/complications , Pneumonia, Bacterial/drug therapy , Pneumonia, Pneumocystis/complications , Pneumonia, Pneumocystis/diagnosis , Pneumonia, Pneumocystis/drug therapy , Polymerase Chain Reaction/veterinary , Quinolones/therapeutic use , Rodent Diseases/drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic useABSTRACT
Spontaneous colonic adenocarcinomas were diagnosed in two rhesus macaques (Macaca mulatta). Although both tumors caused partial obstruction of the colon, they were histologically different. One resembled the commonly described "napkin-ring" adenocarcinoma similar to those found in the descending and sigmoid colon of humans. The other neoplasm, a "tubular" lesion, invaded the full thickness of the colonic wall at the ileocecal-colonic junction. Both tumors were associated with metastasis, which is uncommon in the rhesus monkey.
Subject(s)
Adenocarcinoma/veterinary , Intestinal Neoplasms/veterinary , Macaca mulatta , Monkey Diseases/pathology , Adenocarcinoma/pathology , Animals , Female , Intestinal Neoplasms/pathology , Neoplasm Invasiveness , Neoplasm MetastasisABSTRACT
The lats gene has been identified as a tumour suppressor in Drosophila melanogaster using mosaic screens. Mosaic flies carrying somatic cells that are mutant for lats develop large tumours in many organs. The human LATS1 homologue rescues embryonic lethality and inhibits tumour growth in lats mutant flies, demonstrating the functional conservation of this gene. Biochemical and genetic analyses have revealed that LATS1 functions as a negative regulator of CDC2 (ref. 3). These data suggest that mammalian LATS1 may have a role in tumorigenesis. To elucidate the function of mammalian LATS1, we have generated Lats1-/- mice. Lats1-/- animals exhibit a lack of mammary gland development, infertility and growth retardation. Accompanying these defects are hyperplastic changes in the pituitary and decreased serum hormone levels. The reproductive hormone defects of Lats1-/- mice are reminiscent of isolated LH-hypogonadotropic hypogonadism and corpus luteum insufficiency in humans. Furthermore, Lats1-/- mice develop soft-tissue sarcomas and ovarian stromal cell tumours and are highly sensitive to carcinogenic treatments. Our data demonstrate a role for Lats1 in mammalian tumorigenesis and specific endocrine dysfunction.